NICE recently dismissed the appeal against its approval of this new anticoagulant and has recommended it for for people with non-valvular atrial fibrillation and another risk factor, including being over 75 years old, suffering a previous stroke or transient ischaemic attack, or being aged 65 years or older with one of the following: diabetes mellitus, coronary artery disease or hypertension. A second new oral anticoagulant has also received favourable opinion but is still within the appeal period and final guidance on this one will be published later in the year by NICE.
- Dr Howard MarshallHoward Marshall trained at Leeds University graduating in 1988. After moving to the Midlands for specialist training he gained his MD from the University of Birmingham focusing on Atrioventricular Node Ablation and Pacing in the Treatment of Atrial Fibrillation. » Read More
This is a general term that describes some of the procedures that we perform. Ablation is the process that modifies small parts of the heart muscle that are responsible for the abnormal heart rhythms or palpitations. Usually this is done by heating the area using radiofrequency at the end of a catheter that is placed in contact with the heart muscle.